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Abstract
Background: Adherence to medication regimens is essential for preventing and reducing adverse outcomes
among patients with coronary artery disease (CAD). Greater understanding of the relation between negative illness
perceptions, beliefs about cardiac rehabilitation (CR) and medication adherence may help inform future approaches
to improving medication adherence and quality of life (QoL) outcomes. The aims of the study are: 1) to compare
changes in illness perceptions, beliefs about CR, medication adherence and QoL on entry to a CR programme and
6months later; 2) to examine associations between patients’ illness perceptions and beliefs about CR at baseline
and medication adherence and QoL at 6 months.
Methods: A longitudinal study of 40 patients with CAD recruited from one CR service in Scotland. Patients
completed the Medication Adherence Report Scale, Brief Illness Perception Questionnaire, Beliefs about CR
questionnaire and the Short-Form 12 Health Survey. Data were analysed using the Wilcoxon Signed Ranks test,
Pearson Product Moment correlation and Bayesian multiple logistic regression.
Results: Most patients were men (70%), aged 62.3 mean (SD 7.84) years. Small improvements in ‘perceived
suitability’ of CR at baseline increased the odds of being fully adherent to medication by approximately 60% at 6
months. Being fully adherent at baseline increased the odds of staying so at 6 months by 13.5 times. ‘Perceived
necessity, concerns for exercise and practical barriers’ were negatively associated with reductions in the probability
of full medication adherence of 50, 10, and 50%. Small increases in concerns about exercise decreased the odds of
better physical health at 6 months by about 50%; and increases in practical barriers decreased the odds of better
physical health by about 60%. Patients perceived fewer consequences of their cardiac disease at 6 months.
Conclusions: Patients’ beliefs on entry to a CR programme are especially important to medication adherence at 6
months. Negative beliefs about CR should be identified early in CR to counteract any negative effects on QoL.
Interventions to improve medication adherence and QoL outcomes should focus on improving patients’ negative
beliefs about CR and increasing understanding of the role of medication adherence in preventing a future cardiac
event.
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Background
Patients with a new diagnosis of a cardiac condition are
highly likely to have a change in medication for what is
most likely a long-term condition. Medication adherence is
vital for patients to obtain the best mortality and morbidity
benefits from these medication changes [1]. Adherence is
more than simply a count of medications compliance; the
term adherence encapsulates the concept that there may be
reasons why a patient may be unable or may be unwilling
to take a medication [2–4]. It is important that prescribers
are aware of factors which influence adherence to medica-
tion so that these might be explored during the consult-
ation, so that a management plan can be agreed between
the prescriber and the patient to attain concordance – the
point at which a patient and prescriber are working to the
same identified outcomes [5].
Adherence for long term conditions is poor; the World
Health Organization predicted compliance with medica-
tion for long term conditions at around 50% [6]. There is
a major public health concern here, both in terms of pop-
ulations of patients who are, through lack of adherence,
on suboptimal treatment regimen; as well as to healthcare
providers such as the NHS within the UK who are paying
for medications which are going to waste. A recent esti-
mate from NHS England puts the total figure for pharma-
ceutical waste at £300 million per annum [4]. Symptoms
which lead to the diagnosis of heart disease may differ in
the extreme – silent myocardial infarction (MI), compared
to ST elevation myocardial infarction (STEMI), compared
to stable angina, for example. What is not known is what
effect illness perceptions and treatment beliefs, i.e. beliefs
about CR have on patient’s adherence, as well as what ef-
fect their experiences of CR have on shaping this. Further-
more, there is a need to understand the effect that time
has on patient’s beliefs and QoL, and whether these effects
wane or are maintained.
Method
The aims of the study are: 1) to compare changes in ill-
ness perceptions, beliefs about CR, medication adher-
ence and QoL on entry to a CR programme and 6
months later; 2) to examine associations between pa-
tients’ illness perceptions and beliefs about CR at base-
line and medication adherence and QoL at 6 months.
Study design
This was a longitudinal study of patients with coronary
artery disease.
Setting and participants
Data were collected using a convenience sample of pa-
tients attending a hospital-based CR service in one NHS
Board in northern Scotland between 2014 and 2015. The
number of study subjects was determined by practical
considerations; further details on the sample size and re-
sponse rates are given in the results section. Eligible
patients were aged 45 years or over, had a confirmed
medical diagnosis of CAD, and were on stable doses of
cardiac prevention medication. Patients were excluded if
there were any major co-morbidities such as stroke or
cancer, or psychological or communication limitations
likely to affect their ability to give informed consent.
Recruitment and data collection
Patients were recruited on their initial attendance at the
hospital based CR programme. Study information and
consent forms were distributed by the CR specialists, in
accordance with the inclusion and exclusion criteria.
After receipt of the signed consent forms, the researcher
(PT) posted questionnaire packs to the participant’s
home address or provided a link to the Bristol on-line
survey for completion depending on individual prefer-
ence. Completed questionnaires were returned to the re-
searcher (PT) by post or email. A reminder letter was
sent after 2 weeks. After 6 months the participants were
contacted again to complete follow-up questionnaires.
Ethical approval
This study was approved by the University of Stirling Eth-
ics and Research Committee and the National Research
and Ethics Committee (NRES), North of Scotland (Rec
ref. 13/NS/0152 (IRAS project ID: 133236). A written con-
sent was obtained from all participants in the study.
Instruments
Illness perceptions
Patients’ illness perceptions were assessed using the Brief
Illness Perception Questionnaire (B-IPQ) [7]. The B-IPQ
consists of eight separate items, i.e. consequences, time-
line, personal control, treatment control, identity, illness
concern, coherence (understanding) and emotional rep-
resentation relating to the patient’s illness (i.e. CAD),
each scored from 0 to 10. The cumulative score for
items 1–8 gives a score range of 0 to 80. In order to
compute the overall score, items 3, 4, and 7 were reverse
coded. A higher total score reflects a more threatening
(negative) view of the illness [7]. The B-IPQ also has a
causal representation item (item 9) which requires an
open-ended response (not reported in this paper). The
B-IPQ has demonstrated good validity and test-retest re-
liability in research [7–10]. In the study, Cronbach’s
alpha for the B-IPQ total score was 0.75 for patients.
Beliefs about cardiac rehabilitation
Patients’ beliefs about CR were assessed using the Beliefs
about Cardiac Rehabilitation questionnaire (BCR-Q) [11], a
13 item self-administered tool consisting of four sub-scales:
perceived necessity, 5 items; concerns about exercise, 3
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items; practical barriers, 3 items; and perceived suitability, 2
items. All items on the BCR-Q are rated on a 5-point Likert
scale from 1 = strongly disagree to 5 = strongly agree, with
the exception of one item on the necessity scale i.e. ‘some
aspects of the CR programme are unnecessary for me’,
which is reversed scored. For each sub-scale, the scores are
summed and means obtained: necessity (range 9–21); con-
cerns about exercise (range 3–15); practical barriers (range
3–15); and perceived suitability (range 2–10). The BCR-Q
has been shown to be a valid and reliable measure of beliefs
about CR [11, 12]. Cronbach’s alpha for the 4 sub-scales of
BCR-Q range from 0.68–0.76.
Medication adherence
The self-report Medication Adherence Report Scale
(MARS-5) [13] consists of five items, each representing
a different aspect of medication taking. Respondents in-
dicate how often they engage in the five non-adherent
behaviours, on a 1–5 frequency scale (always, often,
sometimes, rarely, never). Higher scores indicate greater
adherence to cardiac medication. A total score for all
five items was calculated (range from 5 to 25). Scores
were separated into unintentional non-adherence (item
1) and intentional non-adherence (items 2–5). The
MARS-5 has demonstrated good reliability and validity
[13], and it has been used widely in research as a meas-
ure of medication adherence behaviour [14–18]. In the
study, the Cronbach’s alpha was 0.67 for the MARS-5
(total score).
Quality of life
Patients’ QoL was assessed using the Medical Outcomes
Short-Form 12 (version 2) Health Survey (SF-12v2) [19],
which is composed of 12 items. These are aggregated
into two summary components; the physical component
score (PCS) and mental component score (MCS). Rated
items reflect what the individual is able to do function-
ally, how they felt and how they evaluated their health
status. The SF-12v2 scores were calculated following the
norm-based scoring algorithm, using weights derived
from confirmatory factor analysis [20]. The measure has
demonstrated good validity and reliability [19, 21]. In
this study, the Cronbach’s alpha was 0.77 for the PCS
and 0.81 for the MCS.
Socio-demographic and clinical characteristics
Data were gathered on socio-demographics and the clin-
ical characteristics of the participants. Occupation was
identified in accordance with the Office of National Sta-
tistics categories (ONS 1998). The Carstairs index of so-
cial deprivation [22], provided deprivation categories
based on postcode region of social deprivation in
Scotland. Scores range from 1 to 7 and higher categories
indicate greater deprivation (i.e. lower socio-economic
status). Additionally, diagnosis, revascularisation, left
ventricular ejection fraction, cardiac history, co-
morbidity (i.e. hypertension, diabetes), other cardiovas-
cular disease risk factors and current medications were
identified from the patient’s clinical records.
Statistical analysis
Changes in illness perceptions, beliefs about CR, medica-
tion adherence and QoL from baseline to 6 months were
compared using the Wilcoxon Signed Ranks test. We in-
vestigated the strength of the linear relationships be-
tween the outcome variables i.e. medication adherence
(MARS-5) and QoL (PCS, MCS) and independent vari-
ables i.e. illness perceptions (total score) and beliefs
about CR (i.e. necessity, concerns about exercise, bar-
riers and suitability), using Pearson’s Product Moment
correlation. In order to assess whether differences in the
self-reported outcomes i.e. medication adherence, phys-
ical and mental health at 6 months could be explained
by differences in illness perceptions, beliefs about CR in
patients starting a CR programme (baseline), we
employed multiple logistic regression models on the out-
comes, dichotomised as follows: MARS-5 was encoded
at 0 for the group with the lower scores (under 25, sub-
optimal adherence) and 1 for the group with a higher
score (25, optimal adherence). Physical health (PCS) and
mental health (MCS) were encoded 0 for the group with
the lowest score (below 50) (i.e. poorer physical or men-
tal health); and 1 for the group with higher scores (50 or
above) (i.e. better physical or mental health), based on
UK population means [23]. We fitted the model within
the Bayesian framework [24, 25].
Results
Recruitment
Out of the patients approached upon entry to the CR
programme, 56 patients consented to participate and
completed the questionnaires at that time (baseline). At
6 months 40 (71%) of these patients completed the ques-
tionnaires and the data analysis was based on them.
Characteristics of the participants
The socio-demographic and clinical characteristics of
participants are presented in Table 1. Most patients were
men (70%), mean age of 62.30 years (SD = 7.84); 22.5%
had a diagnosis of STEMI, 52.5% with non-ST elevation
myocardial infarction (NSTEMI) and the remainder ei-
ther had unstable angina or stable angina. Most patients
had a percutaneous coronary intervention (Table 1).
Thirty patients (75%) completed the Bristol on-line sur-
vey and 25% completed paper copies of the question-
naire as their preferred method.
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Changes in illness perceptions, beliefs about CR,
medication adherence and quality of life
Table 2 shows the changes in illness perceptions, beliefs
about CR, medication adherence and QoL from baseline
to 6months later. Changes in illness perceptions (B-IPQ)
(total scores) were statistically non-significant, but despite
this the results indicate some negative illness perceptions
with respect to the illness being treatable, higher levels of
concern and general effect of illness on life which prevail
over time. Perceived consequences (individual item B-
IPQ) were statistically significantly reduced from baseline
to 6months, indicating the patients perceived fewer con-
sequences of their disease (z = − 2.827, p = 0.005) (Table 2).
Also, treatment control (z = − 2.132, p = 0.033) and illness
concern (z = − 2.347, p = 0.019) were statistically signifi-
cantly reduced at 6months, which suggests that patients
felt a greater sense that treatment could help their illness
more and there were less concerns about their illness..
There was a trend for increased practical barriers (BCR-
Q) at 6months (z = − 1.905, p = 0.057), but the rest of the
change scores for beliefs about CR were not statistically
significantly different from baseline to 6months (Table 2).
The scores for necessity were high suggesting that patients
were more likely to perceive CR as necessary and be clear
as to how it would be of benefit. The scores for concerns
about exercise were low suggesting that the patients were
less concerned about participating in the exercise compo-
nent of CR i.e. it may be harmful in some way. Similarly,
the scores for practical barriers and perceived suitability
were low indicating that the patients were less likely to
perceive greater practical barriers to attending the CR
programme and less likely to believe that CR is most suit-
able for a younger, more active person.
The medication adherence MARS-5 (total scores)
were high at baseline and 6 months, indicating high
levels of medication adherence (Table 2), which did not
change statistically significantly over time. The uninten-
tional non-adherence score was 4.70 mean (SD 0.56) at
baseline and 4.70 mean (SD 0.51) at 6 months; and the
intentional non-adherence was 20.0 mean (SD 0.0) at
baseline and 6 months. There were no statistically sig-
nificant changes in unintentional non-adherence (item
1) over time (25% vs 27.5%, p = 1.00); and also for
intentional non-adherence (items 2 to 5) (0% vs 0%,
p = 1.00). Table 2 shows the PCS and MCS scores at
baseline and 6 months which indicate sub-optimal
levels of physical and mental health, both of which pre-
vailed over time.
Correlations between illness perceptions, beliefs about
CR, medication adherence and QoL
Table 3 shows that patients’ concerns about exercise
(BCR-Q) at the start of CR were significantly weakly
negatively correlated with their physical health (PCS) at
Table 1 Patients’ characteristics (n = 40)
Characteristics Patients
Age, years (mean, range) 62.45 (45–78)
Male gender 28 (70%)
Marital status
Married 37 (92.5)
Co-habilitating 3 (7.5%)
Employment
Employed 20 (50%)
Unemployed or retired 20 (50%)
Education, years (median, range) 14.0 (7–30)
Social deprivation (SIMD)
SIMD 1–2 10 (25%)
SIMD 3–5, out of area 30 (75%)
Diagnosis
STEMI 9 (22.5%)
NSTEMI 21 (52.5%)
Unstable angina 5 (12.5%)
Stable angina 5 (12.5%)
Revascularisation
Thrombolysis 2 (5%)
PCI 32 (80%)
CABG 1 (2.5%)
Left ventricular ejection fraction
> 50% 21 (52.5%)
30–49% (mild - moderate impairment) 17 (42.5%)
< 29% (severe impairment), or missing 2 (5%)
Cardiac history
PCI 5 (12.5%)
CABG 3 (7.5%)
Myocardial infarction 4 (10%)
Co-morbid conditions
Hypertension 23 (57.5%)
Diabetes mellitus 2 (5%)
Other CVD risk factors
Smoking 16 (40%)
Missing data 10 (25%)
Hypercholesterolaemia 21 (52.5%)
Missing data 2 (5%)
Medications
ACE/ ARB 22/ 3 (62.5%)
Beta blocker 29 (72.5%)
Diuretics 2 (5%)
Antidepressants 6 (15%)
SIMD Scottish Index of Multiple Deprivation, STEMI ST elevation
myocardial infarction, NSTEMI non-ST elevation myocardial infarction, ACE
angiotensin converting enzyme inhibitor, ARB angiotensin
receptor blocker
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6 months (r = − 0.358, p = 0.023). This indicates that
greater concerns about exercise were related to poorer
physical health at 6 months. Also, patients’ poorer phys-
ical health and mental health at baseline were signifi-
cantly weakly positively correlated with their poorer
physical health (PCS) at 6 months (r = 0.327, p = 0.039
and r = 0.356, p = 0.024, respectively (Table 3). More
negative illness perceptions (B-IPQ) and concerns about
exercise (BCR-Q) at baseline were significantly weakly
negatively correlated with poorer mental health (MCS)
at 6 months (r = − 0.343, p 0.030 and r = − 0.457, p =
0.003, respectively) (Table 3). In addition, patients’
poorer mental health at baseline was significantly mod-
erately positively correlated with their poorer mental
health at 6 months (r = 0.596, p < 0.001). Table 3 shows
the additional inter-correlations between variables.
Table 2 Changes in patients’ illness perceptions, beliefs about cardiac rehabilitation, medication adherence and quality of life
Variable Follow-up Median (range) Baseline Median (range) Change scores % Change scores
Illness perceptions
Consequences 2.00 (0–10) 4.00 (0–10) − 2.00* 50.0
Timeline 10.00 (0–10) 9.00 (0–10) 1.00 11.1
Personal control 7.00 (0–10) 7.00 (0–10) 0.00 0.0
Treatment control 8.50 (2–10) 9.00 (4–10) − 0.50* 5.5
Identity 2.00 (0–9) 2.50 (0–9) − 0.50 20.0
Illness concern 4.50 (0–10) 6.50 (0–10) − 2.00* 30.7
Coherence 8.50 (5–10) 9.00 (4–10) − 0.50 5.5
Emotional upset 3.00 (0–9) 3.00 (0–10) 0.00 0.0
Total score 26.50 (4–56) 32.00 (10–55) −5.50 17.2
Beliefs about CR
Necessity 18.50 (10–21) 18.00 (13–21) 0.50 2.7
Concerns-exercise 5.50 (3–14) 6.00 (3–15) −0.50 8.3
Practical barriers 5.00 (3–11) 4.00 (3–12) 1.00 25.0
Suitability 4.00 (2–8) 3.50 (2–10) 0.50 14.2
MARS-5 (total score) 25.0 (23–25) 25.0 (23–25) 0.00 0.0
Quality of life
PCS 52.80 (23.94–62.72) 48.85 (19.08–60.26) 3.95 8.1
MCS 50.61 (24.05–62.25) 47.29 (29.98–61.88) 3.32 7.0
CR cardiac rehabilitation, MARS-5 medication adherence report scale, PCS physical component score, MCS mental component score; *p = < 0.005
Table 3 Correlations among medication adherence and quality of life and illness perceptions/beliefs about cardiac rehabilitation
1 2 3 4 5 6 7 8 9 10 11
Patients (n = =40)
1 MARS-5 (TP2) 1
2 PCS (TP2) −.01 1
3 MCS (TP2) −.01 .15 1
4 Illness perceptions (BIPQ) .02 .20 −.34* 1
5 Necessity (BCRQ) −.22 −.04 −.28 .27 1
6 Exercise concerns (BCRQ) −.05 −.35* −.45* .15 .06 1
7 Barriers (BCRQ) −.10 −.26 −.28 .17 −.14 .53** 1
8 Suitability (BCRQ) .07 −.15 −.07 −.02 −.17 .65** .68** 1
9 MARS-5 .29 .09 .01 −.11 −.11 −.11 −.23* −.02 1
10 PCS −.19 .32* .08 .27 −.01 −.32* .09 −.02 −.01 1
11 MCS .20 .35* .59** −.42** .35* −.43* −.20 −.40 .11 −.11 1
MARS-5 Medication Adherence Report Scale, B-IPQ Brief Illness Perceptions questionnaire, BCR-Q Beliefs about cardiac rehabilitation questionnaire, PCS physical
component score, MCS mental component score, TP2 time-point 2
** p < 0 .01; *p < 0.05
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Impact of illness perceptions, beliefs about CR on
medication adherence & QoL at 6 months
Inspection of Fig. 1 reveals that the model shows per-
ceived suitability and MARS score at baseline (sui_t1
and MARS_t1 in the plot, respectively) to be positively
related with the probability of scoring 1 on the 6-
months dichotomised medication adherence (25 on the
MARS scale), although with different magnitudes. The
posterior distribution for the perceived suitability param-
eter presents most of its mass above 0, and is consistent
with odds between 0.5–6 (point estimate 1.6); the base-
line MARS parameter posterior distribution is almost
entirely above zero, and is consistent with odds between
0.7–330 (point estimate 13.5).
Focussing on the point estimates, these can be inter-
preted as follows: keeping everything else at the mean
level, an additional point on the perceived suitability
scale increases the odds of being fully adherent of ap-
proximately 60%. On the other hand, being fully adher-
ent at baseline increases the odds of staying so at 6
months by 13.5 times (as opposed to non-adherence at
baseline). Perceived necessity, concerns for exercise, and
practical barriers (nec_t1, exe_t1, and bar_t1 in the plot,
respectively) are all associated to posterior distributions
whose mass mostly lie below zero, although to different
extents, meaning they can be interpreted as being overall
negatively associated with the outcome. Specifically, ne-
cessity is consistent with odds between 0.2–1.1 (point
estimate 0.5), concerns about exercise with odds be-
tween 0.4–1.2 (point estimate 0.9), and barriers with
odds between 0.2–1.6 (point estimate 0.5). In terms of
point estimates, these amount to reductions in probabil-
ity of full adherence, all else being kept at the mean
level, of 50, 10, and 50%, respectively for a one-point in-
crease on those scales. Baseline illness perceptions (total
score) seem to have a negligible impact on the outcome
(odds between 0.9–1.2, point estimate 1.0).
Figure 2 shows the posterior distributions for the
model of physical health (PCS) at 6 months.
Physical health at 6 months was found to be negatively
related to concerns for exercise and practical barriers at
baseline (exe_t1 and bar_t1 in the plot, respectively).
The posterior distributions for the concerns for exercise
parameter lies almost entirely below 0, and is consistent
with odds between 0.2–1.2 (point estimate 0.5); most of
the distribution for the practical barriers parameter lies
below zero, and is consistent with odds between 0.1–2.0
(point estimate 0.6). For what concerns the point esti-
mates, these can be interpreted as follows: keeping
everything else at the mean level, an additional point on
the concerns for exercise scale decreases the odds of a
PCS score higher than 50 of approximately 50%, while
Fig. 1 Posterior distributions for the model of medication adherence at 6 months. bip, illness perceptions; nec, perceived necessity of CR; exe,
concerns about exercise; bar, practical barriers to CR; sui, perceived suitability of CR; MARS, Medication Adherence Report Scale
Thomson et al. BMC Cardiovascular Disorders           (2020) 20:71 Page 6 of 11
the same change on the practical barriers scale leads to a
decrease in odds of approximately 60%. The posterior
distributions of the parameters for perceived necessity,
suitability, and physical health at baseline are all more or
less centred around zero, thus making it difficult to as-
sess the existence of an effect on physical health at 6
months. Baseline illness perceptions (total score) seem
to have a negligible impact on the outcome (odds be-
tween 0.9–1.2, point estimate 1.0).
Figure 3 shows the posterior distributions for the
model of mental health (MCS) at 6 months. Mental
health at 6 months is found to be negatively related to
perceived necessity, concerns for exercise and practical
barriers at baseline (nec_t1, exe_t1 and bar_t1, respect-
ively). The posterior distributions for all these parame-
ters lie almost entirely below 0. An increase in perceived
necessity at baseline is consistent with odds between
0.2–1.2 (point estimate 0.6); similarly, we observed that
increases in concerns for exercise were consistent with
odds between 0.2–1.1 (point estimate 0.5), and increases
in practical barriers with odds between 0.1–1.1 (point
estimate 0.4). In terms of point estimates, these can be
interpreted as follows: keeping everything else at the
mean level, an additional point on the scales related to
perceived necessity, concerns for exercise, and practical
barriers decrease the odds of an MCS score higher than
50 by approximately 60, 50, and 40% respectively, while
the same change on the practical barriers scale leads to a
decrease in odds of approximately 60%. Change on the
practical barriers scale leads to a decrease in odds of
approximately 60%. Perceived suitability is slightly posi-
tively related to the outcome, with a posterior distribu-
tion showing values consistent with odds between 0.5–
6.7 (point estimate 1.8), interpretable as an 80% increase
in the odds of an MCS score larger than 50 for a point
increase in perceived suitability. While baseline illness
perception (total score) does not exhibit any evident
impact on MCS at 6 months, the posterior distribution
for baseline MCS scores is consistent with too wide a
range of odds (0.1–40.4, point estimate 1.5) to help draw
reliable conclusions.
Discussion
This study examined whether differences in self-reported
outcomes i.e. medication adherence, physical and mental
health at 6 months could be explained by differences in ill-
ness perceptions and beliefs about CR upon entry to a CR
programme. The results suggest that small changes (i.e.
improvements) in perceived suitability i.e. beliefs about
CR increase the probability of being fully adherent by ap-
proximately 60%. Also, being fully adherent to medication
upon entry to a CR programme increases the odds of
Fig. 2 Posterior distributions for the model of physical health at 6 months. bip, illness perceptions; nec, perceived necessity of CR; exe, concerns
about exercise; bar, practical barriers to CR; sui, perceived suitability of CR; MARS, Medication Adherence Report Scale
Thomson et al. BMC Cardiovascular Disorders           (2020) 20:71 Page 7 of 11
staying so at 6months by 13.5 times. Perceived necessity,
concerns regarding exercise and practical barriers to CR
were negatively associated with reductions in the probabil-
ity of full medication adherence. Previous research has ex-
amined beliefs about CR although mostly in relation to
CR attendance [11, 26, 27]. Our results suggest that pa-
tients’ beliefs about the suitability of CR and medication
adherence at the start of CR are especially important to
medication adherence at 6months. Medication adherence
should be addressed early as part of the CR process as well
as any mistaken beliefs about CR. In our study, patients’
baseline illness perceptions showed no real impact on
medication adherence at 6months, a finding which is
largely consistent with Byrne et al. [28]. Although illness
perceptions and CR attendance and/or secondary preven-
tion have been examined [9, 27, 29], there remains a
paucity of evidence on the relation between illness percep-
tions and medication adherence (outcome) in CAD pa-
tient populations.
Our analysis suggests that physical health (outcome) at
6 months is negatively related to baseline concerns about
exercise and practical barriers [12, 27]. These results are
broadly consistent with Cooper et al. [11], who assessed
beliefs about CR as a basis for predicting CR attendance
after acute MI. As yet, there is a scarcity of research
examining the associations between beliefs about CR
and physical health (outcome), Prior research has shown
that poorer health outcomes for ACS patients may be at-
tributed to non-attendance at, or non-completion of CR
and that high scores for perceived necessity following
discharge predict attendance at CR [26]. It was unclear
in our analysis whether poorer physical health at 6
months was influenced by perceptions of necessity and
suitability, and physical health at baseline. In addition,
we found no real impact of baseline illness perceptions
on physical health at 6 months, which contrasts with
previous research [7, 8, 30–34].
Mental health (outcome) at 6 months was negatively
associated with perceived necessity, concerns for exer-
cise and practical barriers at baseline. No studies were
identified for direct comparison with our results for
mental health, although concerns about the harmful ef-
fects of CR are said to reflect an emotional reaction [11].
Prior research [11, 35], has identified that patients who
hold negative beliefs about CR were less likely to attend
CR. Our correlation analysis revealed that greater base-
line concerns about exercise and negative illness percep-
tions were significantly related to poorer mental health
(outcome) at 6 months. Prior research has established
that patients’ treatment beliefs e.g. beliefs about CR are
not necessarily isolated from their illness beliefs, al-
though mental health was not examined [36].
Fig. 3 Posterior distributions for the model of mental health at 6 months. bip, illness perceptions; nec, perceived necessity of CR; exe, concerns
about exercise; bar, practical barriers to CR; sui, perceived suitability of CR; MARS, Medication Adherence Report Scale
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A further aim of the study was to compare changes in
medication adherence, perceived physical and mental
health, illness perceptions and beliefs about CR upon
entry to a CR programme and 6months later. Despite
our study showing no statistically significant changes in
medication adherence (MARS) upon entry to the CR
programme to 6 months later, it revealed some import-
ant information. The baseline and 6months scores were
high suggesting greater medication adherence; a finding
which is consistent with prior studies with cardiac pa-
tients [28], and stroke survivors [16, 17]. In this study,
75% of patients reported optimal adherence and 25% of
patients reported sub-optimal adherence at baseline; and
72.5% of patients reported optimal adherence and 27.5%
of patients reported sub-optimal adherence at 6 months.
These figures reveal greater medication adherence com-
pared to previous research [14]. In our study, 25% of pa-
tients reported unintentional non-adherence at baseline
and 27.5% of patients at 6 months, compared to 15% at
2 weeks and 52% at 6 months in Molloy et al. [14]. In
our study, the patients stating intentional non-adherence
was zero at baseline and 6months, which is low com-
pared to prior research [14]. Still our results suggest
some unintentional non-adherence to cardiac medica-
tions which should be avoided. Medication adherence is
crucial for successful CR [18], and the prevention of re-
current MI and premature mortality [1].
There were no statistically significant changes in phys-
ical health (PCS) and mental health (MCS) over time.
The scores remained below the population average of 50
[37], which is consistent with other cardiac studies [38–
40]. Our results imply no real impact of CR on QoL, a
finding which is consistent with the RAMIT trial [41].
The evidence, however, is conflicting with previous
studies, reviews and meta-analyses claiming the benefit
for QoL with CR [42, 43]. McKee [44] argues that im-
provements in QoL mainly occur during the CR
programme phase. The patients in our study attended
CR classes 1 day per week for 10 weeks. The study was
not designed as a trial of the ‘efficacy’ of CR but rather
it sought to help clarify the likelihood of increased
medication adherence and better QoL at 6 months hav-
ing considered patients’ illness perceptions and beliefs
about CR at baseline.
Similar to Jones et al. [26], we found, for example, that
perceived necessity of CR did not change significantly
over time, although the baseline scores were high com-
pared to other research [11], suggesting our patients
were more likely to perceive CR as necessary and benefi-
cial. Consistent with prior research [33], our patients re-
ported fewer consequences of their illness over time, a
greater sense of control over their cardiac disease and
less concerns about illness. Compared to attenders at
CR [27], our total B-IPQ scores were high reflecting a
more threatening (negative) view of illness. These dis-
similar findings may be due to the different timing of as-
sessment. The scores for concerns about exercise and
perceived suitability at baseline were low compared to
Cooper et al. [11], indicating our patients were less con-
cerned about the exercise component of CR and less
likely to believe that it was more suitable for a younger
more active person. Despite these findings, there were
still some erroneous beliefs about CR suggesting some
room for improvement. Individuals may be less likely to
continue participating in CR if incorrect beliefs about
CR are not targeted [11, 33].
Strengths and limitations
Patients were recruited from a standard CR service, but
this was a relatively small convenience sample of CAD
patients which may limit generalisability to the wider
UK population. Strengths of the study lie in its longitu-
dinal design and in the selection of antecedent variables
(i.e. illness perceptions and beliefs about CR) that to our
knowledge have not been used before in combination to
assess associations with medication adherence and QoL
outcomes at 6 months. Individual items on the B-IPQ
were not analysed separately in the logistic regression
and this may have obscured some significant findings.
Given the overall high medication adherence scores
there may have been some reporting bias. However, the
wording of the MARS has been shown to reduce a social
desirability effect [17], and the measure has been shown
to correspond to more objective measures of adherence
such as the Medication Event Monitoring System
(MEMS) [45], and it is considered to be more practical
in the rehabilitation setting [46]. Overall, beliefs about
CR featured highly in this study with respect to medica-
tion adherence and QoL. Considering the uniqueness of
these results more research is needed using a larger sam-
ple size to confirm or refute our findings.
Conclusion
Our results suggest that patients’ beliefs at the start of a
CR programme are especially important to medication
adherence at 6 months. In addition, being fully adherent
to medication upon entry to a CR programme increases
the odds of staying so at 6 months. Physical and mental
health at 6 months was negatively associated with base-
line beliefs about CR. Negative beliefs about CR should
be identified early as part of CR to counteract any nega-
tive effects on QoL. Interventions to improve medication
adherence and QoL outcomes should focus on improv-
ing patients’ negative beliefs about CR and increasing
understanding of the role of medication adherence in
preventing a future cardiac event.
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